UK breast radiotherapy trial passes 1,000 participants
A government-funded study is testing whether a shorter course with a targeted boost can reduce hospital visits safely.
What the record says
The UK Department of Health and Social Care said October 30 that more than 1,000 people had joined the FAST-Forward Boost trial at 39 UK hospitals.
Researchers are testing whether breast radiotherapy with an additional targeted dose can be shortened from three weeks to five days, potentially avoiding ten hospital trips. The announcement reports recruitment, not successful trial results.
Led by the Institute of Cancer Research and funded through NIHR, the study aims to recruit 4,830 people by 2028. Participants will be followed for five years, with results expected in 2033.
Source details and supporting locations.
Practical next step
Patients should discuss treatment choices with their own cancer team; this milestone does not change individual care.
Limits and what is not established
Safety and effectiveness of the trial approach remain under study. Potential travel and capacity benefits depend on its results.
Sources checked November 1, 2026. Later notices may change instructions or arrangements.
Original sources
UK Department of Health and Social Care: original information